The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes.

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Danish pharmaceutical company, Novo Nordisk, has launched its successful diabetes and weight-loss drug, Ozempic, in India ...

Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four ...

Guava, as a fruit, is a rich source of vitamin C and makes a powerful immunity booster. It is also rich in antioxidants that ...

Curating evidence-based lifestyle recommendations is key to achieving ideal cardiometabolic health in patients with obesity, as there is no “one-size-fits-all,” according to a presentation.At World ...

With this launch, Ozempic now available in India as a once-weekly injectable formulation of semaglutide. It will be available ...

Protein and carbohydrate macronutrients (nutrients we need a lot of) have been discussed in recent columns. Today’s column is ...

Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, pricing the lowest dose of 0 ...